Alimera Sciences Inc. (ALIM) announced the positive outcome of the Decentralized Procedure for ILUVIEN in Europe Tuesday morning.
Alimera Sciences gapped up sharply Tuesday morning and is now higher by 1.63 at $3.94, with trading volume already over a 3-month high. The stock has jumped to a 3 1/2 month high.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.